Carbapenem-Susceptible OXA-23-Producing Proteus mirabilis in the French Community | Zendy

Anaïs Potron | Zendy; Didier Hocquet | Zendy; Pauline Triponney | Zendy; Patrick Plésiat | Zendy; Xavier Bertrand | Zendy; Benoı̂t Valot | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Carbapenem-Susceptible OXA-23-Producing Proteus mirabilis in the French Community

Author(s) -

Anaïs Potron,

Didier Hocquet,

Pauline Triponney,

Patrick Plésiat,

Xavier Bertrand,

Benoı̂t Valot

Publication year - 2019

Publication title -

antimicrobial agents and chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.07

H-Index - 259

eISSN - 1070-6283

pISSN - 0066-4804

DOI - 10.1128/aac.00191-19

Subject(s) - proteus mirabilis , microbiology and biotechnology , biology , carbapenem , clone (java method) , proteus infections , proteus , antibiotics , gene , bacteria , pseudomonas aeruginosa , genetics , escherichia coli

NineteenProteus mirabilis isolates producing the carbapenemase OXA-23 were recovered over a 2-year period in 19 French hospitalized patients, of whom 12 had community onset infections. The isolates exhibited a slightly reduced susceptibility to carbapenems.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research